Diagnosis of Viral Respiratory Infections, 2nd Edition
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Diagnostic Microbiology and Infectious Disease".
Deadline for manuscript submissions: 30 April 2026 | Viewed by 439
Special Issue Editor
2. Clinical Microbiology Laboratory, Hospital of Circolo and Estabilshment Macchi, Varese, Italy
Interests: respiratory viruses; microbiology infection
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Respiratory tract infections (RTIs) are a major cause of morbidity and mortality in humans. With around 3 million people dying from RTI-related causes each year, RTIs are one of the leading causes of death worldwide. Between 50% and 90% of RTIs are caused by respiratory viruses (RVs). These include human rhinovirus (HRV), influenza A and B virus (IAV and IBV), human respiratory syncytial virus (HRSV) and human metapneumovirus (HMPV), human coronaviruses (HCoVs) and human adenovirus (HAdV), parainfluenzavirus (HPIV), and human adenovirus (HAdV). The highest rates of morbidity and mortality from RTIs are found in infants, the elderly, and immunocompromised individuals. However, healthy individuals without underlying risk factors can also be affected. The recent acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has increased awareness of the dramatic effect that respiratory infections can have on human and global health.
Prior to the SARS-CoV-2 pandemic, viral lower respiratory tract infections (LRTIs) and upper respiratory tract infections (URTIs) were underappreciated causes of critical illness within the population. As the current pandemic has demonstrated, there are limited options for the prophylaxis and treatment of viral RTIs. Vaccines are available for some viruses, such as influenza and adenovirus, but both efficacy and coverage are suboptimal.
The recent implementation of vaccines in the field of respiratory syncytial virus (RSV) has enabled the control of its circulation, particularly among vulnerable groups such as newborns and the elderly. Nevertheless, studies investigating the effects of prophylaxis on RSV are ongoing, employing whole-genome sequencing (WGS) and immunological techniques.
This Special Issue welcomes submissions related to the monitoring of respiratory infections, the epidemiology of respiratory viruses, and the possible impacts of respiratory virus diseases, as well as respiratory virus sequencing by WGS. In particular, we encourage submissions that study cases or clusters of viral variants in small and large communities and the detection of unusual epidemiological events, as well as the genomic characteristics and immunological aspects.
Dr. Federica Novazzi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- respiratory tract infections
- lower respiratory tract infections (LRTIs)
- upper respiratory tract infections (URTIs)
- whole-genome sequencing (WGS)
- immunological techniques
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
